<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Antepartum Hemorrhage and PPROM - National Guidelines</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon">üè†</span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="03-anc-and-preconception.html" class="nav-button">
                        <span class="nav-icon">‚Üê</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 22%;"></div>
                        </div>
                       <span class="progress-text">Section 4 of 18</span>
                    </div>
                    <a href="05-preterm-labor-and-birth.html" class="nav-button">
                        <span class="nav-text">Next: Preterm Labor & Birth</span>
                        <span class="nav-icon">‚Üí</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">ANTEPARTUM HEMORRHAGE</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                
                <!-- START: aph-introduction -->
                <section id="aph-introduction" class="content-section">
                    <h2>Definition</h2>
                    <div class="content-card">
                        <p>Antepartum hemorrhage (APH) is defined as bleeding from or into the genital tract occurring after 24 weeks of gestation which is unrelated to labor and delivery. Any vaginal bleeding after 24 weeks should be assumed to be due to either placenta previa or placental abruption, unless proven otherwise.</p>

                        <h3>Causes</h3>
                        <ul class="enhanced-list">
                            <li>Placenta previa (20 percent)</li>
                            <li>Placental abruption (30 percent)</li>
                            <li>Uterine rupture (rare)</li>
                            <li>Vasa previa (rare)</li>
                            <li>Cervical Lesions</li>
                            <li>Vaginal lesions</li>
                            <li>Unidentified causes</li>
                        </ul>
                        <p><strong>Prediction:</strong> APH has a heterogeneous pathophysiology and cannot reliably be predicted</p>
                    </div>
                </section>
                <!-- END: aph-introduction -->

                <!-- START: aph-diagnosis -->
                <section id="aph-diagnosis" class="content-section">
                    <h2>Diagnosis</h2>
                    <div class="content-card">
                        <h3>Clinical history to identify:</h3>
                        <ul class="enhanced-list">
                            <li>The possible causes of bleeding</li>
                            <li>The gestational age and presence of ultrasound reports of the current pregnancy</li>
                            <li>Any history of bleeding in previous pregnancies</li>
                            <li>Duration taken since onset of bleeding</li>
                            <li>Any medical attention sought</li>
                            <li>Fetal status in terms of movement</li>
                            <li>Any clinical symptoms indicative of shock</li>
                        </ul>

                        <h3>Assessment of the mother's and baby's condition</h3>
                        <h4>Maternal assessment</h4>
                        <ul class="enhanced-list">
                            <li>Signs of shock (Pallor, sweating, cold and clammy, restlessness)</li>
                            <li>Pulse rate-tachycardia if in shock</li>
                            <li>Blood pressure- expected hypotension</li>
                            <li>Uterine palpation for size, tenderness, softness/hardness</li>
                        </ul>
                        <aside class="callout warning" role="alert">
                            <h4 class="callout-title"><span class="callout-icon">‚ö†Ô∏è</span> NB</h4>
                            <p>Vaginal examination should not be performed until ultrasound is done to exclude placenta praevia</p>
                        </aside>

                        <h4>Fetal Assessment</h4>
                        <ul class="enhanced-list">
                            <li>Presence of or absence of fetal heart (Differentiate from maternal pulse due to maternal tachycardia)</li>
                            <li>Closely monitor fetal heart if present for gestation of over 28 weeks</li>
                            <li>Auscultation with Doppler, pinnards or fetoscope</li>
                        </ul>

                        <h4>Diagnosis is mainly clinical with the following raising suspicion:</h4>
                        <ul class="enhanced-list">
                            <li>Per vaginal bleeding associated with or without abdominal pains.</li>
                            <li>Uterus is tender and, irritable,</li>
                            <li>Signs of shock i.e. maternal tachycardia, hypotension</li>
                            <li>Evidence of fetal distress if abruption'</li>
                        </ul>
                        <p>Ultrasound is helpful when ruling out placenta praevia and in assessing fetal condition</p>
                    </div>
                </section>
                <!-- END: aph-diagnosis -->

                <!-- START: aph-resuscitation -->
                <section id="aph-resuscitation" class="content-section">
                    <h2>Initial Resuscitation and General Management</h2>
                    <div class="content-card">
                        <p><strong>SHOUT FOR HELP!!! To urgently mobilize all available personnel.</strong></p>
                        <p>Perform a rapid evaluation of the woman's general condition and then start DR. ABC protocol;</p>
                        <ul class="enhanced-list">
                            <li><strong>D</strong> - Danger</li>
                            <li><strong>R</strong> - Response</li>
                            <li>Airway</li>
                            <li>Breathing</li>
                            <li>Circulation</li>
                        </ul>
                        <p>Evaluate the level of consciousness (AVPU; A- alertness, V-verbal response, P- pulse, U- Unresponsive).</p>

                        <figure>
                            <img src="../assets/images/2025_11_24_1f5d3abc0b734f89226ag-094-1.jpg" alt="Figure 15: Resuscitation steps for Antepartum hemorrhage (APH)" class="content-image">
                            <figcaption>Figure 15: Resuscitation steps for Antepartum hemorrhage (APH)</figcaption>
                        </figure>

                        <p>Perform secondary review to assess presence of anxiety and/or confusion, volume of blood loss, whether bleeding is accompanied by pain, color and temperature of skin.</p>
                        <aside class="callout danger" role="alert">
                            <h4 class="callout-title"><span class="callout-icon">üõë</span> Do not do a vaginal examination at this Stage.</h4>
                        </aside>
                        <p>If shock is suspected, immediately position appropriately and begin treatment. Pregnant uterus compresses vena cava causing blood pressure to drop there is need to provide a left lateral tilt.</p>

                        <h3>How to Position Pregnant Woman: > 20 weeks</h3>
                        <figure>
                            <img src="../assets/images/2025_11_24_1f5d3abc0b734f89226ag-095-1.jpg" alt="Figure 16: Positioning of a pregnant woman with more than 20 weeks gestation pregnancy" class="content-image">
                            <figcaption>Figure 16: Positioning of a pregnant woman with more than 20 weeks gestation pregnancy</figcaption>
                        </figure>

                        <h3>Check the fetal heart rate and ask about fetal movements:</h3>
                        <ul class="enhanced-list">
                            <li>If there are fetal heart rate abnormalities (less than 110 or more than 160 beats per minute), suspect fetal distress.</li>
                            <li>If fetal heart cannot be heard, ask several other persons to listen or use a Doppler, stethoscope, if available.</li>
                        </ul>
                        <p>If fetal movements are not felt, the fetal heart cannot be heard, suspect fetal death. Start an IV infusion and infuse IV fluids.</p>
                        <aside class="callout warning" role="alert">
                            <h4 class="callout-title"><span class="callout-icon">‚ö†Ô∏è</span> NB</h4>
                            <p>Send a blood sample for haemoglobin or haematocrit and type and screen, and order blood for possible transfusion, before IV fluids infusion. For the classification of shock (in stages) refer to the section on 'Shock'</p>
                        </aside>
                    </div>
                </section>
                <!-- END: aph-resuscitation -->

                <!-- START: placenta-previa -->
                <section id="placenta-previa" class="content-section">
                    <h2>PLACENTA PREVIA</h2>
                    <div class="content-card">
                        <p>Placenta Previa refers to the implantation of the placenta over or near the internal os of the cervix.</p>
                        <p>All placentas overlying the os (to any degree) are termed as Previa and those near to but not overlying the os are termed low-lying.</p>
                        <p>Placenta Previa is commonly diagnosed by ultrasonography in the third trimester, often between 28 and 32 weeks.</p>
                        <p><strong>Epidemiology:</strong> The estimated global prevalence of placenta previa was 5.2 per 1000 pregnancies in 2014'</p>

                        <h3>Types of Placenta Previa</h3>
                        <figure>
                            <img src="../assets/images/2025_11_24_1f5d3abc0b734f89226ag-096-1.jpg" alt="Figure 17: Types of Placenta Previa" class="content-image">
                            <figcaption>Figure 17: Types of Placenta Previa</figcaption>
                        </figure>

                        <p>Placenta Previa is divided into four categories according to the distance from placental edge to internal os.</p>
                        <div class="table-container">
                            <table class="content-table">
                                <thead>
                                    <tr>
                                        <th>Classifications of Placenta Previa</th>
                                        <th>Position</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr><td>Type I (low-lying placenta)</td><td>Placenta encroaches the lower segment, and does not reach internal os.</td></tr>
                                    <tr><td>Type II (marginal)</td><td>Placenta reaches the margin of internal os but does not cover it.</td></tr>
                                    <tr><td>Type III (partial)</td><td>Placenta partially covers the internal os.</td></tr>
                                    <tr><td>Type IV (complete/total)</td><td>Placenta completely covers the internal os, the cervix cannot dilate.</td></tr>
                                </tbody>
                            </table>
                        </div>

                        <h3>Risk factors / Signs/ Symptoms</h3>
                        <p>Several risk factors implicated in placenta Previa.</p>
                        <ul class="enhanced-list">
                            <li>Multi-parity</li>
                            <li>Prior cesarean delivery</li>
                            <li>Multi-fetal pregnancy</li>
                            <li>Older maternal age</li>
                        </ul>
                        <p>Deficient endometrium due to presence or history of:</p>
                        <ul class="enhanced-list">
                            <li>Uterine scar</li>
                            <li>Endometritis</li>
                            <li>Manual removal of placenta</li>
                            <li>Curettage</li>
                            <li>Sub mucous fibroid</li>
                            <li>Assisted conception</li>
                            <li>Previous termination of pregnancy</li>
                            <li>Previous placenta Praevia</li>
                            <li>Smoking</li>
                        </ul>

                        <h3>Signs and symptoms</h3>
                        <ul class="enhanced-list">
                            <li>Painless bleeding</li>
                            <li>Bright red blood variable in amount</li>
                            <li>Pale looking patient, the degree of which corresponds to the amount of blood loss.</li>
                            <li>No tenderness in the abdomen</li>
                            <li>Soft and relaxed uterus</li>
                            <li>The presenting part may be high or there may be abnormal presentation</li>
                            <li>The fetal parts are easily palpable</li>
                            <li>Fetal heart sounds are usually present.</li>
                        </ul>

                        <h3>Algorithm on management of Antepartum Hemorrhage</h3>
                        <figure>
                            <img src="../assets/images/2025_11_24_1f5d3abc0b734f89226ag-098-1.jpg" alt="Figure 18: Flow chart showing the management of placenta previa" class="content-image">
                            <figcaption>Figure 18: Flow chart showing the management of placenta previa</figcaption>
                        </figure>
                    </div>
                </section>
                <!-- END: placenta-previa -->

                <!-- START: placenta-abruption -->
                <section id="placenta-abruption" class="content-section">
                    <h2>PLACENTAL ABRUPTION</h2>
                    <div class="content-card">
                        <p>Placental abruption refers to the premature separation of a normally implanted placenta from the uterus before the delivery of the fetus.</p>
                        <p><strong>Epidemiology:</strong> Present in an estimated 0.4-1% of pregnancies, placental abruption is a major cause of perinatal death and maternal morbidity</p>

                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 18: Classification of placental abruption</caption>
                                <thead>
                                    <tr>
                                        <th>Classification</th>
                                        <th>Descriptions</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr><td>Class 0: Asymptomatic</td><td><ul><li>Discovery of a blood clot on the maternal side of a delivered placenta</li><li>Retrospective diagnosis</li></ul></td></tr>
                                    <tr><td>Class 1: Mild</td><td><ul><li>Minimal or no vaginal bleeding.</li><li>Slight uterine tenderness</li><li>Normal maternal blood pressure and pulse</li><li>No signs of fetal distress</li></ul></td></tr>
                                    <tr><td>Class 2: Moderate</td><td><ul><li>No sign of vaginal bleeding to moderate amount of vaginal bleeding</li><li>Significant uterine tenderness with tetanic contractions</li><li>Maternal tachycardia, orthostatic changes in blood pressure</li><li>Evidence of fetal distress</li></ul></td></tr>
                                    <tr><td>Class 3: Severe</td><td><ul><li>No sign of vaginal bleeding to heavy bleeding</li><li>Tetanic uterus/ board-like consistency on palpation</li><li>Maternal shock</li><li>Coagulopathy and hypofibrigonemia</li><li>Fetal death</li></ul></td></tr>
                                    <tr><td colspan="2">The existing clinical criteria of severity rely exclusively on fetal (fetal distress or fetal death) and maternal complications without consideration of neonatal or preterm delivery-related complications</td></tr>
                                </tbody>
                            </table>
                        </div>

                        <h3>The following are Implicated in Placental Abruption</h3>
                        <ul class="enhanced-list">
                            <li>Older maternal age (>35 years)</li>
                            <li>Hypertension (pregnancy-induced or chronic)</li>
                            <li>Placental ischemia (ischemic placental disease) manifesting as intrauterine growth restriction</li>
                            <li>Polyhydramnios</li>
                            <li>Intra-amniotic infection (chorioamnionitis)</li>
                            <li>Vasculitis</li>
                            <li>Other vascular disorders</li>
                            <li>Prior placental abruption</li>
                            <li>Abdominal trauma/ gender-based violence</li>
                            <li>Acquired maternal thrombotic disorders</li>
                            <li>Tobacco use</li>
                            <li>Premature rupture of membranes</li>
                            <li>Cocaine use (risk of up to 10%)</li>
                        </ul>

                        <h3>Signs and symptoms</h3>
                        <p>Varies widely depending on site, extent and type.</p>
                        <ul class="enhanced-list">
                            <li>Vaginal bleeding</li>
                            <li>Revealed: amount of visible blood loss commensurate with level of shock</li>
                            <li>Concealed: amount of external blood loss disproportionate with features of anaemia or shock that patient presents with</li>
                            <li>Abdominal pain</li>
                            <li>Uterine tenderness</li>
                            <li>Woody hard, tense uterus</li>
                            <li>Backache - especially with posterior placenta</li>
                            <li>Acute fetal distress</li>
                            <li>Fetal demise(IUFD)</li>
                            <li>Preterm labour</li>
                            <li>Hypovolemic shock</li>
                        </ul>

                        <h3>Algorithm on management of placenta abruption</h3>
                        <figure>
                            <img src="../assets/images/2025_11_24_1f5d3abc0b734f89226ag-101-1.jpg" alt="Figure 19: Flow chart showing the management of placenta abruption" class="content-image">
                            <figcaption>Figure 19: Flow chart showing the management of placenta abruption</figcaption>
                        </figure>

                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 20: Complications of antepartum hemorrhage</caption>
                                <thead>
                                    <tr>
                                        <th>Maternal Complications</th>
                                        <th>Fetal Complications</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>
                                            <ul>
                                                <li>Anemia</li>
                                                <li>Infection</li>
                                                <li>Maternal shock</li>
                                                <li>Renal tubular necrosis</li>
                                                <li>Consumptive coagulopathy (DIC)</li>
                                                <li>Postpartum hemorrhage</li>
                                                <li>Prolonged hospital stay</li>
                                                <li>Psychological sequelae</li>
                                                <li>Complications of blood transfusion</li>
                                            </ul>
                                        </td>
                                        <td>
                                            <ul>
                                                <li>Small for gestational age and fetal growth restriction</li>
                                                <li>Prematurity (iatrogenic and spontaneous)</li>
                                                <li>Fetal death</li>
                                                <li>Fetal hypoxia</li>
                                            </ul>
                                        </td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                    </div>
                </section>
                <!-- END: placenta-abruption -->

                <!-- START: pprom -->
                <section id="pprom" class="content-section">
                    <h1 class="section-title">PRETERM PRELABOUR RUPTURE OF MEMBRANES</h1>
                    <div class="content-card">
                        <h2>Introduction</h2>
                        <p>Pre-Labour Rupture of Membranes (PROM) refers to spontaneous rupture of membrane before the onset of uterine contractions. Previously the condition was referred to as premature rupture of membranes.</p>
                        <p>Preterm Pre-labour Rupture of Membranes (PPROM) refers to spontaneous rupture of membranes occurs beyond 28 weeks but before 37 completed week's gestation and least one hour before the onset of labour</p>

                        <h2>Epidemiology</h2>
                        <p>PPROM occurs in about 3% of pregnancies. It varies considerably between different areas due to different population risk factors.</p>
                        <p>Preterm pre-labour rupture of membranes is the primary etiology for 40% of pre-term births. It is the single most common identifiable factor associated with preterm delivery. It precedes about 30-40% of spontaneous preterm labour. 30-40% of women with PPROM will deliver within 48 hours and 56 to 63% within 7 days.</p>
                        <p>PPROM can lead to significant perinatal morbidity including: Birth asphyxia, Respiratory Distress Syndrome (RDS), neonatal sepsis, umbilical cord prolapse, placental abruption and fetal death.</p>
                        <p>It has been established that preterm birth is a significant risk factor for long term sequelae such as chronic lung disease, neurosensory impairment, cerebral palsy and developmental delay.</p>
                        <p>The 3 major causes of death associated with PPROM are: prematurity, neonatal sepsis and pulmonary hypoplasia.</p>
                        <p>PPROM may be complicated by chorioamnionitis which together with retained products of conception are the major causes of secondary postpartum hemorrhage.</p>

                        <h3>Summary recommendations</h3>
                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 21: Summary recommendations on preterm pre-labour rupture of membranes</caption>
                                <thead>
                                    <tr>
                                        <th>Recommendation</th>
                                        <th>Grading of evidence</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr><td>1. Avoid digital examination unless immediate induction is planned as this has been shown to increase the rate of infection</td><td>Consensus</td></tr>
                                    <tr><td>2. If there are no maternal or fetal contraindications, recommend expectant management to women with PPROM before 34+0 weeks gestation</td><td>Level A</td></tr>
                                    <tr><td>3. Recommend antibiotics (as identified in the guideline) to women with PPROM to reduce maternal and neonatal infection</td><td>Level A</td></tr>
                                    <tr><td>4. Recommend antenatal corticosteroids to women with PPROM less than 35+0 weeks gestation</td><td>Level A</td></tr>
                                    <tr><td>5. Recommend intrapartum antibiotic prophylaxis for Early Onset Group B Streptococcal Disease to women with PPROM</td><td>Level A</td></tr>
                                </tbody>
                            </table>
                        </div>

                        <h3>Etiology</h3>
                        <p>Causative factors are multifactorial. Infection appears to have an important role, either as a cause or as a consequence of PPROM and is an independent risk factor for subsequent cerebral palsy.</p>
                        <p>There is evidence demonstrating an association between ascending infection from the lower genital tract and PPROM</p>
                        <p>In majority, the causes are not known, however possible risk factors include:</p>

                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 22: Possible Risk Factors to PPROM</caption>
                                <tbody>
                                    <tr><td>1</td><td>Previous history of PPROM</td><td>7</td><td>Decreased tensile strength of the membranes</td></tr>
                                    <tr><td>2</td><td>Genital tract infection or colonization with: Chlamydia trachomatis, Neisseria gonorrhea, Bacterial vaginosis, Group B streptococcus, Gardnerella vaginalis</td><td>8</td><td>Cervical incompetence</td></tr>
                                    <tr><td>3</td><td>Multiple gestation</td><td>9</td><td>Cervical length &lt; 2.5 cm (short cervix)</td></tr>
                                    <tr><td>4</td><td>Polyhydramnios</td><td>10</td><td>Abruption placentae and Placenta Previa</td></tr>
                                    <tr><td>5</td><td>Increased friability of the membranes</td><td>11</td><td>Iatrogenic (Invasive procedures amniocentesis, fetal blood sampling)</td></tr>
                                    <tr><td>6</td><td>Fetal malformations</td><td>12</td><td>Trauma</td></tr>
                                </tbody>
                            </table>
                        </div>

                        <h3>Clinical Presentation</h3>
                        <p>The only subjective symptom is escape of watery discharge per vagina either in the form of a gush or slow leak. This is often confused with Hydrorrhea gravidarum; a state where periodic watery discharge occurs probably due to excessive decidual glandular secretion and incontinence of urine especially in the last trimester.</p>

                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 23: Signs and Symptoms of PROM</caption>
                                <thead>
                                    <tr>
                                        <th>Signs</th>
                                        <th>Symptoms</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>
                                            <ul>
                                                <li>Decrease in size of the uterus</li>
                                                <li>Temperature may be raised (above 37.2¬∞C)</li>
                                                <li>Intermittent or slow leaking from the vagina soaking a vulva pad.</li>
                                                <li>Fluid seen escaping from cervical canal on speculum examination is diagnostic</li>
                                                <li>An increase in fetal rate</li>
                                                <li>Increased white blood cell count</li>
                                            </ul>
                                        </td>
                                        <td>
                                            <ul>
                                                <li>Abnormally heavy watery vaginal discharge which may run up to the feet or a sudden gush of fluid from the vagina.</li>
                                                <li>The fluid may be clear/transparent, pink, yellow, green or brown and may be foul smelling The fluid may leak constantly OR only when walking, standing, after sitting, lying down or on exertion</li>
                                                <li>There may be fever, chills or abdominal pains</li>
                                                <li>Contraction and tenderness of the uterus</li>
                                            </ul>
                                        </td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>

                        <h3>Assessment of a patient with PPROM</h3>
                        <h4>Obstetric history</h4>
                        <p>The following information should be obtained from the patient</p>
                        <ul class="enhanced-list">
                            <li>Last menstrual period, regularity of the menstrual cycles and hence duration of gestation</li>
                            <li>History of similar episode in previous pregnancies</li>
                            <li>Duration of drainage and amount of fluid</li>
                            <li>Pattern of fetal movements</li>
                        </ul>

                        <h4>Physical Examination</h4>
                        <ul class="enhanced-list">
                            <li>General examination with vital sign monitoring</li>
                            <li>Abdominal examination for any tenderness</li>
                            <li>Obstetric examination- Leopold's maneuvers</li>
                            <li>Vaginal examination: Sterile speculum examination is done taking aseptic precautions to check for any cord prolapse, presenting fetal parts.</li>
                        </ul>
                        <p>Inspect the liquor escaping out through the cervix; color and consistency, features of vernix and meconium staining. The patient may be asked to perform a Valsalva maneuver or cough to confirm leakage. Collect fluid for analysis from the posterior fornix (vaginal pool)</p>

                        <h4>Investigations</h4>
                        <p><strong>Laboratory investigations</strong></p>
                        <ul class="enhanced-list">
                            <li>Full blood count: Hb, WBC (total and differential count), ESR</li>
                            <li>pH test: Detection of pH by litmus or Nitrazine paper. The pH becomes 6-6.2 (Normal vaginal pH during pregnancy is 4.5-5.5 whereas that of liquor amnii is 7-7.5).</li>
                        </ul>
                        <p>Nitrazine paper turns from yellow to blue at pH >6. Competing differential diagnoses of a positive nitrazine test include: vaginal infections, blood, semen, cervical mucous - all of which cause an alkaline vaginal PH.</p>
                        <ul class="enhanced-list">
                            <li>Nile blue sulfate test: Centrifuged cells stained with 0.1% Nile blue sulfate show orange blue coloration of the cells (exfoliated fat containing cells from sebaceous glands of the fetus)</li>
                            <li>Phosphatidyl glycerol and Lecithin Sphingomyelin ratio of the draining liquor to assess fetal lung maturity</li>
                            <li>Urinalysis</li>
                            <li>HIV</li>
                            <li>TB Screening</li>
                        </ul>
                        <p>Note the characteristic ferning pattern when a smeared slide is examined under the microscope</p>

                        <p><strong>Microbiology</strong></p>
                        <ul class="enhanced-list">
                            <li>Amniotic fluid for microscopy, culture and sensitivity</li>
                            <li>High vaginal swab for microscopy, culture and sensitivity</li>
                            <li>Urine culture, microscopy and sensitivity</li>
                        </ul>

                        <p><strong>Imaging</strong></p>
                        <ul class="enhanced-list">
                            <li>Obstetric ultrasound for fetal biophysical profile and to determine: viability, maturity, amount of liquor, any fetal abnormalities and presentation</li>
                        </ul>

                        <p><strong>Cardiotocography</strong></p>
                        <ul class="enhanced-list">
                            <li>For a non-stress test. Indeed, fetal tachycardia is used in definition of clinical chorioamnionitis</li>
                        </ul>

                        <h3>Treatment</h3>
                        <p>Once the diagnosis is confirmed, management depends on: -</p>
                        <ul class="enhanced-list">
                            <li>Gestational age of the fetus</li>
                            <li>Whether the patient is in labor or not</li>
                            <li>Any evidence of sepsis</li>
                            <li>Prospect of fetal survival in that institution, if delivery occurs</li>
                        </ul>

                        <h4>Principles of treatment</h4>
                        <ul class="enhanced-list">
                            <li>The main concern is to balance the risk of infection in expectant management (while pregnancy is continued) versus the risk of prematurity in active intervention.</li>
                            <li>Vaginal digital examination is generally avoided to prevent infection</li>
                            <li>Ideally the patient should be transferred with the "fetus in utero" to a unit able to manage preterm neonates effectively.</li>
                            <li>If the gestational age is 34 weeks or more, perinatal mortality from prematurity is less compared to infection.</li>
                            <li>Labor generally starts spontaneously within 48 hours; otherwise, induction with oxytocin is instituted.</li>
                            <li>Presentation other than cephalic merits cesarean section.</li>
                            <li>When gestational age is less than 34 weeks, conservative attitude generally followed in absence of any maternal or fetal indications.</li>
                            <li>On rare occasions with bed rest, the leak seals spontaneously and pregnancy continues.</li>
                        </ul>

                        <h4>Supportive treatment modalities</h4>
                        <ul class="enhanced-list">
                            <li>Admit the patient</li>
                            <li>Patient is put on bed rest and a sterile vulval pad is applied to observe any further leakage.</li>
                            <li>Continuous fetal monitoring</li>
                            <li>Maternal vital signs monitoring i.e., pulse and temperature</li>
                            <li>Monitoring for uterine tenderness by abdominal palpation is performed.</li>
                        </ul>

                        <h4>Use of antibiotics</h4>
                        <p>Prophylactic antibiotics are given to minimize maternal and perinatal risks of infection. Studies have shown that prophylactic antibiotics prolong pregnancy and reduce maternal and neonatal sepsis.</p>

                        <p><strong>Recommendations for antibiotic use</strong></p>
                        <ul class="enhanced-list">
                            <li>Following PPROM at 32 weeks' gestation, antibiotics should be administered to women who are not in labour in order to prolong pregnancy and to decrease maternal and neonatal morbidity (I-A).</li>
                            <li>The use of antibiotics should be gestational-age dependent. The evidence for benefit is greater at earlier gestational ages (<32 weeks) (I-A).</li>
                            <li>For women with PPROM at >32 weeks' gestation, administration of antibiotics to prolong pregnancy is recommended if fetal lung maturity cannot be proven and/or delivery is not planned (I-A).</li>
                            <li>Antibiotic regimens may consist of an initial parenteral phase followed by an oral phase, or may consist of only an oral phase (I-A).</li>
                            <li>Antibiotics of choice are penicillin or macrolide antibiotics (erythromycin) in parenteral and/or oral forms. (I-A) In patients allergic to penicillin, macrolide antibiotics should be used alone (III-B).</li>
                            <li>The following two regimens may be used (the two regimens were used in the largest PPROM randomized controlled trials that showed a decrease in both maternal and neonatal morbidity): (1) ampicillin 2 g IV every 6 hours and erythromycin 250 mg IV every 6 hours for 48 hours followed by amoxicillin 250 mg orally every 8 hours and erythromycin 500 mg orally every 8 hours for 5 days (I-A); (2) erythromycin 500 mg orally every 6 hours for 10 days (IA). Used if there is no evidence of maternal chorioamnionitis.</li>
                            <li>Amoxicillin/clavulanic acid should not be used because of an increased risk of necrotizing enterocolitis in neonates exposed to this antibiotic. Amoxicillin without clavulanic acid is safe (I-A).</li>
                            <li>Women presenting with PPROM should be screened for urinary tract infections, sexually transmitted infections, and group B streptococcus carriage, and treated with appropriate antibiotics if positive (II-2B).</li>
                        </ul>

                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 24: The dosages of antenatal corticosteroid use</caption>
                                <thead>
                                    <tr>
                                        <th colspan="2">
                                            Corticosteroids are effective in preventing adverse perinatal outcomes, most notably respiratory distress syndrome, and in increasing the likelihood of neonatal survival<br>
                                            Repeated doses of corticosteroids reduce the occurrence and severity of neonatal lung disease and the risk of serious health problems in the first few weeks of life
                                        </th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Single course</td>
                                        <td>
                                            <strong>Indications</strong>
                                            <ul>
                                                <li>Gestational age is between $23^{+0}$ and $34^{+6}$ weeks and in PTL</li>
                                                <li>Risk of preterm imminent birth</li>
                                                <li>Preterm birth is planned or expected within the next seven days</li>
                                            </ul>
                                            <strong>Dosage</strong>
                                            <ul>
                                                <li>Administer IM betamethasone in two doses of 11.4 mg (5.7 mg x 2) 24 hours apart to the woman</li>
                                                <li>If betamethasone is unavailable, give IM dexamethasone in two doses of 12 mg, 24 hours apart</li>
                                            </ul>
                                            <ul>
                                                <li>Where appropriate, estimate the risk of preterm birth by considering the use of adjunct prediction tests including fetal fibronectin and assessment of cervical length</li>
                                            </ul>
                                        </td>
                                    </tr>
                                    <tr>
                                        <td>Repeat course(s)</td>
                                        <td>
                                            <strong>Indications</strong>
                                            <ul>
                                                <li>When the gestational age is <strong>32+6</strong> days or less, a repeat antenatal corticosteroid dose may be given 7 days or more after the first course in women still considered at risk of early preterm birth</li>
                                            </ul>
                                            <strong>Dosage</strong>
                                            <ul>
                                                <li>Either: A single repeat dose of IM betamethasone 11.4 mg IM (5.7 mg x 2)</li>
                                                <li>OR A single repeat course of IM betamethasone in two doses of 11.4 mg (5.7 mg x 2) 24 hours apart</li>
                                                <li>If betamethasone is unavailable, give IM dexamethasone 12 mg</li>
                                            </ul>
                                        </td>
                                    </tr>
                                    <tr>
                                        <td>Further repeat single dose(s)</td>
                                        <td>
                                            <ul>
                                                <li>Seven days after the first, single, repeat dose (and less than 14 days since the first repeat dose), if the woman is still considered to be at risk of preterm birth within the next seven days, a further, single, repeat dose of antenatal corticosteroids (IM betamethasone 11.4 mg IM [ 5.7 mg x 2 ]) can be given</li>
                                                <li>Use up to a maximum of three, single, repeat doses only</li>
                                                <li>NB: Do not give any further repeat courses if a single repeat course ( 11.4 mg , as two intramuscular doses, 24 hours apart) of betamethasone has been given already</li>
                                            </ul>
                                        </td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <p><em>Footnote: Imtramuscular Betamethasone available locally in 12 Mg</em></p>

                        <h4>Magnesium sulphate for neuroprotection of the fetus</h4>
                        <p>Studies have shown that magnesium sulphate given before preterm birth has a neuroprotective role in the fetus.</p>
                        <p>A loading dose of 4 g IV with a maintenance infusion of 1 g/hr is recommended and should be given for a maximum of 24 hours.</p>

                        <h4>Tocolysis</h4>
                        <ul class="enhanced-list">
                            <li>Prophylactic tocolysis in women with PPROM without uterine activity is not recommended.</li>
                            <li>Women with PPROM and uterine activity who require intrauterine transfer or antenatal corticosteroids may be considered for a short course of tocolysis. However, this decision needs to be considered in light of the possibility of pre-existing intrauterine infection, the only clinical feature of which might be uterine activity. If there is a significant suspicion of chorioamnionitis, then tocolysis is not recommended</li>
                        </ul>

                        <h4>Amnioinfusion</h4>
                        <p>There is some evidence to show that restoring amniotic fluid volume with saline or a similar fluid (amnioinfusion) following preterm premature rupture of the membranes (PPROM) may be beneficial for preterm babies (by preventing infection, lung damage and death) and mothers (by preventing infection of the womb after childbirth). However, current evidence is insufficient to recommend amnioinfusion for routine use in PPROM.</p>

                        <h4>Chorioamnionitis and PPROM</h4>
                        <p>The diagnosis of chorioamnionitis relies on the clinical presentation and may be difficult in its early manifestations.</p>
                        <p>The clinical picture may include maternal fever with 2 or more of the following:</p>
                        <ul class="enhanced-list">
                            <li>Increased white cell count >15*10^9/l</li>
                            <li>Maternal tachycardia (>100bpm)</li>
                            <li>Fetal tachycardia (>160bpm)</li>
                            <li>Uterine tenderness</li>
                            <li>Offensive smelling vaginal discharge</li>
                            <li>C-Reactive Protein >40</li>
                        </ul>
                        <p>If signs of chorioamnionitis, use:</p>
                        <ul class="enhanced-list">
                            <li>Ampicillin or amoxicillin 2 g IV every 6 hours</li>
                            <li>Gentamicin 5 mg/kg IV daily</li>
                            <li>Metronidazole 500 mg IV every 12 hours</li>
                            <li>If allergic to penicillin, give clindamycin 600 mg IV in 50-100 ml over at least 20 minutes every 8 hours and gentamicin 5 mg/kg IV daily until recovery</li>
                        </ul>

                        <h3>Assessment and management of Preterm prelabour rupture of the membranes (PPROM)</h3>
                        <figure>
                            <img src="../assets/images/2025_11_24_1f5d3abc0b734f89226ag-112-1.jpg" alt="Figure 20: Algorithm on approach to a patient with PPROM" class="content-image">
                            <figcaption>Figure 20: Algorithm on approach to a patient with PPROM</figcaption>
                        </figure>
                    </div>
                </section>
                <!-- END: pprom -->

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon">üè†</span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="03-anc-and-preconception.html" class="nav-button">
                        <span class="nav-icon">‚Üê</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 22%;"></div>
                        </div>
                       <span class="progress-text">Section 4 of 18</span>
                    </div>
                    <a href="05-preterm-labor-and-birth.html" class="nav-button">
                        <span class="nav-text">Next: Preterm Labor & Birth</span>
                        <span class="nav-icon">‚Üí</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>